A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration ( Wld S ) mouse
Open accessAbstract
Exons of three genes were identified within the 85-kilobase tandem triplication unit of the slow Wallerian degeneration mutant mouse, C57BL/ Wld S . Ubiquitin fusion degradation protein 2 ( Ufd2 ) and a previously undescribed gene, D4Cole1e , span the proximal and distal boundaries of the repeat unit, respectively. They have the same chromosomal orientation and form a chimeric gene when brought together at the boundaries between adjacent repeat units in Wld S . The chimeric mRNA is abundantly expressed in the nervous system and encodes an in-frame fusion protein consisting of the N-terminal 70 amino acids of Ufd2 , the C-terminal 302 amino acids of D4Cole1e , and an aspartic acid formed at the junction. Antisera raised against synthetic peptides detect the expected 43-kDa protein specifically in Wld S brain. This expression pattern, together with the previously established role of ubiquitination in axon degeneration, makes the chimeric gene a promising candidate for Wld . The third gene altered by the triplication, Rbp7 , is a novel member of the cellular retinoid-binding protein family and is highly expressed in white adipose tissue and mammary gland. The whole gene lies within the repeat unit leading to overexpression of the normal transcript in Wld S mice. However, it is undetectable on Northern blots of Wld S brain and seems unlikely to be the Wld gene. These data reveal both a candidate gene for Wld and the potential of the Wld S mutant for studies of ubiquitin and retinoid metabolism.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The protective effects in WldS mice are attributed to a chimeric gene Ube4b/NMNAT1, which encodes an in-frame fusion protein of the amino-terminal of UBE4B and the complete coding region of NMNAT1.
“The protective effects occurring in these mice are attributed to a chimeric gene Ube4b/NMNAT1, which encodes an in-frame fusion protein of the amino-terminal of ubiquitination factor E4B (UBE4B) and the complete coding region of NMNAT1 (83,84).”
From CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy (2012) · cites this paper as [83]
The Results identify a WldS-specific in-frame fusion of the N-terminal 70 amino acids of Ufd2 and the C-terminal 302 amino acids of D4Cole1e. The Abstract and Discussion call it a promising candidate for slowing Wallerian degeneration, not an established cause of protection. Our copy does not identify D4Cole1e as NMNAT1 or say that the fusion contains NMNAT1’s complete coding region. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No references could be resolved yet.
Research works printed but not linked: 29
- [1]Lunn E R, Perry V H, Brown M C, Rosen H, Gordon S. Eur J Neurosci. 1989;1:27–33. doi: 10.1111/j.1460-9568.1989.tb00771.x. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
- [2]Waller A. Philos Trans R Soc London. 1850;140:423–429. [Google Scholar]
- [3]Dal Canto M C, Gurney M E. Brain Res. 1995;676:25–40. doi: 10.1016/0006-8993(95)00063-v. [DOI] [PubMed] [Google Scholar] · DOI
- [4]Fujimura H, Lacroix C, Said G. Brain. 1991;114:1929–1942. doi: 10.1093/brain/114.4.1929. [DOI] [PubMed] [Google Scholar] · DOI
- [5]Buckmaster E A, Perry V H, Brown M C. Eur J Neurosci. 1995;7:1596–1602. doi: 10.1111/j.1460-9568.1995.tb01155.x. [DOI] [PubMed] [Google Scholar] · DOI
- [6]Finn J T, Weil M, Archer F, Siman R, Srinivasan A, Raff M C. J Neurosci. 2000;20:1333–1341. doi: 10.1523/JNEUROSCI.20-04-01333.2000. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
- [7]Bernier B, Castejon S, Culver D G, Glass J D. NeuroReport. 1999;10:1423–1426. doi: 10.1097/00001756-199905140-00007. [DOI] [PubMed] [Google Scholar] · DOI
- [8]Lyon M F, Ogunkolade B W, Brown M C, Atherton D J, Perry V H. Proc Natl Acad Sci USA. 1993;90:9717–9720. doi: 10.1073/pnas.90.20.9717. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
- [9]Coleman M P, Conforti L, Buckmaster E A, Tarlton A, Ewing R M, Brown M C, Lyon M F, Perry V H. Proc Natl Acad Sci USA. 1998;95:9985–9990. doi: 10.1073/pnas.95.17.9985. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
- [10]Timmerman V, Nelis E, Van Hul W, Nieuwenhuijsen B W, Chen K L, Wang S, Ben Othmane K, Cullen B, Leach R J, Hanemann C O, et al. Nat Genet. 1992;1:171–175. doi: 10.1038/ng0692-171. [DOI] [PubMed] [Google Scholar] · DOI
- [11]de The H, Chomienne C, Lanotte M, Degos L, Dejean A. Nature (London) 1990;347:558–561. doi: 10.1038/347558a0. [DOI] [PubMed] [Google Scholar] · DOI
- [12]Kleinjan D J, van Heyningen V. Hum Mol Genet. 1998;7:1611–1618. doi: 10.1093/hmg/7.10.1611. [DOI] [PubMed] [Google Scholar] · DOI
- [13]Conforti L, Buckmaster E A, Tarlton A, Brown M C, Lyon M F, Perry V H, Coleman M P. Mamm Genome. 1999;10:617–622. doi: 10.1007/s003359901056. [DOI] [PubMed] [Google Scholar] · DOI
- [14]Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd Ed. Plainview, NY: Cold Spring Harbor Lab. Press; 1989. [Google Scholar]
- [15]Chomczynski P, Sacchi N. Anal Biochem. 1978;162:156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar] · DOI
- [16]Liu F-T, Zinnecker M, Hamaoka T, Katz D H. Biochemistry. 1979;18:690–697. doi: 10.1021/bi00571a022. [DOI] [PubMed] [Google Scholar] · DOI
- [17]Koegl M, Hoppe T, Schlenker S, Ulrich H D, Mayer T U, Jentsch S. Cell. 1999;96:635–644. doi: 10.1016/s0092-8674(00)80574-7. [DOI] [PubMed] [Google Scholar] · DOI
- [18]Smith W C, Nakshatri H, Leroy P, Rees J, Chambon P. EMBO J. 1991;10:2223–2230. doi: 10.1002/j.1460-2075.1991.tb07758.x. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
- [19]Nakshatri H, Chambon P. J Biol Chem. 1994;269:890–902. [PubMed] [Google Scholar]
- [20]Mori H, Kondo J, Ihara Y. Science. 1987;235:1641–1644. doi: 10.1126/science.3029875. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
- [21]Li K, Ito H, Tanaka K, Hirano A. J Neuropathol Exp Neurol. 1997;56:125–131. doi: 10.1097/00005072-199702000-00002. [DOI] [PubMed] [Google Scholar] · DOI
- [22]DiFiglia M, Sapp E, Chase K O, Davies S W, Bates G P, Vonsattel J P, Aronin N. Science. 1997;277:1990–1993. doi: 10.1126/science.277.5334.1990. [DOI] [PubMed] [Google Scholar] · DOI
- [23]Cummings C J, Mancini M A, Antalffy B, DeFranco D B, Orr H T, Zoghbi H Y. Nat Genet. 1998;19:148–154. doi: 10.1038/502. [DOI] [PubMed] [Google Scholar] · DOI
- [24]Spittaels K, Van den Haute C, Van Dorpe J, Bruynseels K, Vandezande K, Laenen I, Geerts H, Mercken M, Sciot R, Van Lommel A, et al. Am J Pathol. 1999;155:2153–2165. doi: 10.1016/S0002-9440(10)65533-2. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
- [25]Li G L, Farooque M. Acta Neuropathol. 1996;91:155–160. doi: 10.1007/s004010050407. [DOI] [PubMed] [Google Scholar] · DOI
- [26]Saigoh K, Wang Y L, Suh J G, Yamanishi T, Sakai Y, Kiyosawa H, Harada T, Ichihara N, Wakana S, Kikuchi T, et al. Nat Genet. 1999;23:47–51. doi: 10.1038/12647. [DOI] [PubMed] [Google Scholar] · DOI
- [27]Sidell N, Altman A, Haussler M R, Seeger R C. Exp Cell Res. 1983;148:21–30. doi: 10.1016/0014-4827(83)90184-2. [DOI] [PubMed] [Google Scholar] · DOI
- [28]Troen G, Eskild W, Fromm S H, De Luca L M, Ong D E, Wardlaw S A, Reppe S, Blomhoff R. J Nutr. 1999;129:1621–1627. doi: 10.1093/jn/129.9.1621. [DOI] [PubMed] [Google Scholar] · DOI
- [29]Ghyselinck N B, Bavik C, Sapin V, Mark M, Bonnier D, Hindelang C, Dierich A, Nilsson C B, Hakansson H, Sauvant P, et al. EMBO J. 1999;18:4903–4914. doi: 10.1093/emboj/18.18.4903. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
Cited by
Sorted by citations
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648 · see citing works
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
Araki, T., Sasaki, Y., & Milbrandt, J. (2004) · Science · doi:10.1126/science.1098014 · Cited by 1,060 · see citing works
Clinical progression in Parkinson disease and the neurobiology of axons
Cheng, H., Ulane, C. M., & Burke, R. E. (2010) · Annals of Neurology · doi:10.1002/ana.21995 · Cited by 1,012 · see citing works
“The mutation was identified as an 85kb tandem triplication, which results in a novel chimeric mRNA that encodes for the N-terminal 70 amino acids of ubiquitination factor E4B, followed by the complete coding sequence for the nicotinamide adenine dinucleotide-synthesizing enzyme nicotinamide mononucleotide adenylyltran…”
BackgroundThe secret life of NAD+: an old metabolite controlling new metabolic signaling pathways
Houtkooper, R. H., Cantó, C., Wanders, R. J., & Auwerx, J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0026 · Cited by 899 · see citing works
Axon degeneration mechanisms: Commonality amid diversity
Coleman, M. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1788 · Cited by 819 · see citing works
Self-citationBogan, K. L., & Brenner, C. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155443 · Cited by 707 · see citing works
Berger, F., Lau, C., Dahlmann, M., & Ziegler, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508660200 · Cited by 508 · see citing works
Endogenous Nmnat2 Is an Essential Survival Factor for Maintenance of Healthy Axons
Gilley, J., & Coleman, M. P. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000300 · Cited by 472 · see citing works
Self-citationSirtuin Functions in Health and Disease
Yamamoto, H., Schoonjans, K., & Auwerx, J. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0079 · Cited by 480 · see citing works
Seigneurin-Berny, D., Verdel, A., Curtet, S., Lemercier, C., Garin, J., Rousseaux, S., & Khochbin, S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.23.8035-8044.2001 · Cited by 335 · see citing works
Brown, K. D., Maqsood, S., Huang, J.-Y., Pan, Y., Harkcom, W., Li, W., Sauve, A., Verdin, E., & Jaffrey, S. R. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.11.003 · Cited by 277 · see citing works
Sasaki, Y., Araki, T., & Milbrandt, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2320-06.2006 · Cited by 269 · see citing works
Axon pruning: An essential step underlying the developmental plasticity of neuronal connections
Low, L. K., & Cheng, H.-J. (2006) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2006.1883 · Cited by 258 · see citing works
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration
Di Stefano, M., Nascimento-Ferreira, I., Orsomando, G., Mori, V, Gilley, J., Brown, R., Janeckova, L., Vargas, M. E., Worrell, L. A., Loreto, A., et al. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.164 · Cited by 246 · see citing works
“Wld is a modified nicotinamide mononucleotide adenylyltransferase 1 (NMNAT1) enzyme, whose N-terminal extension partially relocates NMNAT1 from nuclei to axons, conferring gain of function.(9,10) In mammals, three NMNAT isoforms, nuclear NMNAT1, cytoplasmic NMNAT2 and mitochondrial NMNAT3, catalyse nicotinamide adenin…”
BackgroundSelf-citationP7C3 Neuroprotective Chemicals Function by Activating the Rate-Limiting Enzyme in NAD Salvage
Wang, G., Han, T., Nijhawan, D., Theodoropoulos, P., Naidoo, J., Yadavalli, S., Mirzaei, H., Pieper, A. A., Ready, J. M., & McKnight, S. L. (2014) · Cell · doi:10.1016/j.cell.2014.07.040 · Cited by 243 · see citing works
Protective effects and mechanisms of sirtuins in the nervous system
Zhang, F., Wang, S., Gan, L., Vosler, P. S., Gao, Y., Zigmond, M. J., & Chen, J. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.09.001 · Cited by 211 · see citing works
Yahata, N., Yuasa, S., & Araki, T. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4304-08.2009 · Cited by 154 · see citing works
Zhang, X., Kurnasov, O. V., Karthikeyan, S., Grishin, N. V., Osterman, A. L., & Zhang, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300073200 · Cited by 136 · see citing works
Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress
Press, C., & Milbrandt, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0525-08.2008 · Cited by 137 · see citing works
“and the full-length nicotinamide mononucleotide adenylyltransferase 1 (Nmnat1) protein (Conforti et al., 2000).”
BackgroundInfluentialLjungberg, M. C., Ali, Y. O., Zhu, J., Wu, C.-S., Oka, K., Zhai, R. G., & Lu, H.-C. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr492 · Cited by 107 · see citing works
NMNATs, evolutionarily conserved neuronal maintenance factors
Ali, Y. O., Li-Kroeger, D., Bellen, H. J., Zhai, R. G., & Lu, H.-C. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.07.002 · Cited by 91 · see citing works
Metabolic Vulnerability in the Neurodegenerative Disease Glaucoma
Inman, D. M., & Harun-Or-Rashid, M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00146 · Cited by 88 · see citing works
Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity
Yan, T., Feng, Y., Zheng, J., Ge, X., Zhang, Y., Wu, D., Zhao, J., & Zhai, Q. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2009.09.007 · Cited by 92 · see citing works
- Authors
- Conforti, L., Tarlton, A., Mack, T. G. A., Mi, W., Buckmaster, E. A., Wagner, D., Perry, V. H., & Coleman, M. P.
- Affiliations
- University of Oxford (GB)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2000-10-10
- Volume
- 97
- Issue
- 21
- Pages
- 11377-11382
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC17208
- OpenAlex
- W2149931901
- Cited by
- 251
- References
- 0
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 7 · 2021: 9 · 2020: 3 · 2019: 7 · 2018: 3 · 2017: 4 · 2016: 9 · 2015: 8 · 2014: 8 · 2013: 13 · 2012: 14
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
- Keywords
- fusion genes, axonal degeneration, ubiquitination, vitamin A metabolism, candidate genes
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Central Nervous System, Exons, Fungal Proteins, Mice, Inbred C57BL, Molecular Sequence Data, Nicotinamide-Nucleotide Adenylyltransferase, Proteins, Recombinant Fusion Proteins, Retinol-Binding Proteins, RNA, Messenger, Wallerian Degeneration, Sequence Homology, Amino Acid, Peripheral Nervous System, DNA, Complementary, Saccharomyces cerevisiae Proteins, Ubiquitin-Conjugating Enzymes, Mice, Retinol-Binding Proteins, Cellular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review